Todd Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Todd Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$128M	Buy	3,790,007 +18,335	+0.5%	+$611K	2.28%	2
2026 Q1	$114M	Sell	3,771,672 -5,465	-0.1%	-$176K	2.22%	1
2025 Q4	$118M	Sell	3,777,137 -259,460	-6%	-$6.39M	2.3%	1
2025 Q3	$81.5M	Buy	4,036,597 +112,477	+3%	+$1.98M	1.65%	1
2025 Q2	$65.8M	Buy	3,924,120 +991,378	+34%	+$16M	1.42%	12
2025 Q1	$45.1M	Buy	2,932,742 +290,154	+11%	+$5.18M	1.06%	29
2024 Q4	$58.2M	Buy	+2,642,588	New	+$48.1M	1.4%	14
2016 Q4	–	Sell	-213,622	Closed	-$9.83M	–	225
2016 Q3	$9.83M	Sell	213,622 -139,789	-40%	-$7.29M	0.3%	136
2016 Q2	$17.8M	Buy	353,411 +559	+0.2%	+$29.8K	0.57%	69
2016 Q1	$18.9M	Buy	352,852 +189,361	+116%	+$11.1M	0.56%	70
2015 Q4	$10.7M	Buy	+163,491	New	+$10.1M	0.33%	114
2015 Q2	–	Sell	-52,110	Closed	-$3.25M	–	241
2015 Q1	$3.25M	Buy	+52,110	New	+$3.03M	0.09%	157

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Todd Asset Management's TEVA Position: Q2 2026 in Review

Todd Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 0.49% in Q2 2026, buying an estimated $611K and bringing the position to 3,790,007 shares worth $128M. The position accounts for 2.28% of the portfolio, ranked #2.

Todd Asset Management first reported a position in TEVA in Q1 2015 and has held it in 12 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Todd Asset Management held 3,790,007 shares of Teva Pharmaceuticals worth $128M as of Q2 2026.
Todd Asset Management bought 18,335 Teva Pharmaceuticals shares in Q2 2026, an estimated $611K.
Teva Pharmaceuticals made up 2.28% of Todd Asset Management's portfolio in Q2 2026, its #2 holding.
Todd Asset Management first reported a position in Teva Pharmaceuticals in Q1 2015 and has held it in 12 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Todd Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.